Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose IV Thiamine for Delirium Prevention in HSCT
NCT03263442Phase 2Completed
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Start
- Oct 2017
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiamine in delirium, sponsored by UNC Lineberger Comprehensive Cancer Center. Started Oct 2017; status: completed.
02
Drugs
thiamine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT03263442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03263442.